Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruixiao Lu

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Urology|April 30, 2017
Use of a 17-Gene Prognostic Assay in Contemporary Urologic Practice: Results of an Interim Analysis in an Observational CohortGregg Eure, Raymond Germany, Robert Given, et al.
BMC Bioinformatics|July 22, 2008
Assessing probe-specific dye and slide biases in two-color microarray dataRuixiao Lu, Geun-Cheol Lee, Michael Shultz, et al.
European Urology|October 10, 2017
A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized DiseaseStephen K Van Den Eeden, Ruixiao Lu, Nan Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2024
Improving Collection and Analysis of Overall Survival DataLisa R Rodriguez, Nicole J Gormley, Ruixiao Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2020
17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) CohortDaniel W Lin, Yingye Zheng, Jesse K McKenney, et al.
Cell Reports. Medicine|December 12, 2023
Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 TrialRosa I Gallagher, Julia Wulfkuhle, Denise M Wolf, et al.
Annals of Surgical Oncology|October 6, 2016
Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In SituJennifer B Manders, Henry M Kuerer, Benjamin D Smith, et al.
BMJ Open|June 6, 2022
I-SPY COVID adaptive platform trial for COVID-19 acute respiratory failure: rationale, design and operationsDaniel Clark Files, Michael A Matthay, Carolyn S Calfee, et al.
Cancer Cell|May 27, 2022
Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapiesDenise M Wolf, Christina Yau, Julia Wulfkuhle, et al.
JAMA Network Open|December 28, 2023
Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast CancerBeverly Kyalwazi, Christina Yau, Michael J Campbell, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Urology|April 30, 2017
Use of a 17-Gene Prognostic Assay in Contemporary Urologic Practice: Results of an Interim Analysis in an Observational CohortGregg Eure, Raymond Germany, Robert Given, et al.
BMC Bioinformatics|July 22, 2008
Assessing probe-specific dye and slide biases in two-color microarray dataRuixiao Lu, Geun-Cheol Lee, Michael Shultz, et al.
European Urology|October 10, 2017
A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized DiseaseStephen K Van Den Eeden, Ruixiao Lu, Nan Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2024
Improving Collection and Analysis of Overall Survival DataLisa R Rodriguez, Nicole J Gormley, Ruixiao Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2020
17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) CohortDaniel W Lin, Yingye Zheng, Jesse K McKenney, et al.
Cell Reports. Medicine|December 12, 2023
Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 TrialRosa I Gallagher, Julia Wulfkuhle, Denise M Wolf, et al.
Annals of Surgical Oncology|October 6, 2016
Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In SituJennifer B Manders, Henry M Kuerer, Benjamin D Smith, et al.
BMJ Open|June 6, 2022
I-SPY COVID adaptive platform trial for COVID-19 acute respiratory failure: rationale, design and operationsDaniel Clark Files, Michael A Matthay, Carolyn S Calfee, et al.
Cancer Cell|May 27, 2022
Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapiesDenise M Wolf, Christina Yau, Julia Wulfkuhle, et al.
JAMA Network Open|December 28, 2023
Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast CancerBeverly Kyalwazi, Christina Yau, Michael J Campbell, et al.
Pageof 2